Pilot study of lonafarnib, a farnesyl transferase inhibitor, in patients with chronic myeloid leukemia in the chronic or accelerated phase that is resistant or refractory to imatinib therapy
Gautam Borthakur, Hagop Kantarjian, George Daley, Moshe Talpaz, Susan O'Brien, Guillermo Garcia-Manero, Francis Giles, Stefan Faderl, Mary Sugrue, Jorge Cortes*
Dive into the research topics of 'Pilot study of lonafarnib, a farnesyl transferase inhibitor, in patients with chronic myeloid leukemia in the chronic or accelerated phase that is resistant or refractory to imatinib therapy'. Together they form a unique fingerprint.